المؤلفون: Neven, P, Fasching, P A, Chia, S, Jerusalem, Guy, De Laurentiis, M, Im, S-A, Petrakova, K, Bianchi, G V, Martín, M, Nusch, A, Sonke, G S, De la Cruz-Merino, L, Beck, J T, Zarate, J P, Wang, Y, Chakravartty, A, Wang, C, Slamon, D J

المصدر: Breast Cancer Research, 25 (1), 103 (2023-08-31)

مصطلحات موضوعية: Advanced breast cancer, CDK4/6 inhibitor, First line, Overall survival, Ribociclib, Fulvestrant, ribociclib, Humans, Female, Proportional Hazards Models, Postmenopause, Breast Neoplasms/drug therapy, Breast Neoplasms, Oncology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie

العلاقة: urn:issn:1465-5411; urn:issn:1465-542X

الوصول الحر: https://orbi.uliege.be/handle/2268/313198Test

المؤلفون: Sylvie Le Mouhaer, Mark Clemons, Walter Jonat, Laurence Bourdeau, Barbara Pistilli, Javier Cortes, Carlos L. Arteaga, Dalila Sellami, Banu Sankaran, Yoshinori Ito, Sara A. Hurvitz, Ling Min Tseng, Seock–Ah –A Im, Ahmad Awada, José Baselga, Mona El-Hashimy, Stephen Chia, Zefei Jiang, Mario Campone, Agnieszka Jagiełło-Gruszfeld, Norikazu Masuda, Hiroji Iwata, Michele De Laurentiis

المساهمون: Campone, M., Im, S. -A., Iwata, H., Clemons, M., Ito, Y., Awada, A., Chia, S., Jagiello-Gruszfeld, A., Pistilli, B., Tseng, L. -M., Hurvitz, S., Masuda, N., Cortes, J., De Laurentiis, M., Arteaga, C. L., Jiang, Z., Jonat, W., Le Mouhaer, S., Sankaran, B., Bourdeau, L., El-Hashimy, M., Sellami, D., Baselga, J.

المصدر: European Journal of Cancer. 103:147-154

مصطلحات موضوعية: 0301 basic medicine, Oncology, Morpholine, Cancer Research, medicine.medical_specialty, Morpholines, Population, Buparlisib, Aminopyridines, Breast Neoplasms, Placebo, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Internal medicine, Statistical significance, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Overall survival, education, Adverse effect, Fulvestrant, education.field_of_study, Antineoplastic Combined Chemotherapy Protocol, Hormone receptor-positive breast cancer, business.industry, Cancer, ctDNA, PIK3CA, Middle Aged, medicine.disease, Survival Analysis, Postmenopause, Aminopyridine, 030104 developmental biology, chemistry, Hormone receptor, 030220 oncology & carcinogenesis, Female, business, Breast Neoplasm, Human, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4de6dea03664991c98fc5c9f269298b4Test
https://doi.org/10.1016/j.ejca.2018.08.002Test